financetom
Business
financetom
/
Business
/
US FDA approves Denali's genetic disorder therapy
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US FDA approves Denali's genetic disorder therapy
Mar 25, 2026 8:47 AM

March 25 (Reuters) - The U.S. Food and Drug

Administration has approved Denali Therapeutics' ( DNLI )

therapy for a rare genetic disorder, the regulator said on

Wednesday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Vericel Insider Sold Shares Worth $499,900, According to a Recent SEC Filing
Vericel Insider Sold Shares Worth $499,900, According to a Recent SEC Filing
May 21, 2024
04:12 PM EDT, 05/21/2024 (MT Newswires) -- Jonathan Mark Hopper, Chief Medical Officer, on May 20, 2024, sold 10,000 shares in Vericel ( VCEL ) for $499,900. Following the Form 4 filing with the SEC, Hopper has control over a total of 58,116 shares of the company, with 58,116 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/887359/000114036124027027/xslF345X03/form4.xml ...
US airlines seek air traffic control hiring, FAA hits back
US airlines seek air traffic control hiring, FAA hits back
May 21, 2024
WASHINGTON, May 21 (Reuters) - The trade group for major U.S. airlines on Tuesday urged the government to act quickly to address a long-standing air traffic controller shortage ahead of the busy summer travel season but the U.S. Federal Aviation Administration chief accused the group of trying to deflect responsibility for flight delays. Nick Calio, head of Airlines for America,...
Column: WarnerMedia seeks to disqualify mass arbitration firm, alleges ethics breaches
Column: WarnerMedia seeks to disqualify mass arbitration firm, alleges ethics breaches
May 21, 2024
(The opinions expressed here are those of the author, a columnist for Reuters.) By Alison Frankel May 21 (Reuters) - WarnerMedia is seeking to disqualify plaintiffs firm Zimmerman Reed from representing claimants in a mass arbitration campaign against the entertainment conglomerate, accusing the law firm's managing partner of committing serious ethical breaches. Warner's petition to disqualify, filed last week in...
-- Aya Gold & Silver Brief: After Model Updates, National's NAVPS Increased By 3% to C$12.55 (was C$12.18)
-- Aya Gold & Silver Brief: After Model Updates, National's NAVPS Increased By 3% to C$12.55 (was C$12.18)
May 21, 2024
03:51 PM EDT, 05/21/2024 (MT Newswires) -- Price: 15.43, Change: -0.05, Percent Change: -0.32 ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved